Literature DB >> 23289592

Seminal transmission of lumpy skin disease virus in heifers.

C H Annandale1, D E Holm, K Ebersohn, E H Venter.   

Abstract

It is known that lumpy skin disease virus (LSDV) can be shed in bull semen following infection and also that artificial insemination (AI) poses a biosecurity risk. However, it is not known whether the use of LSDV infected semen in AI poses a biosecurity risk. The aim of this study was to investigate whether LSDV, transmitted through semen, can infect cows and their embryos. Two controlled trials were performed simultaneously. Eleven young beef heifers, naïve to LSDV, were synchronized using an OvSynch protocol and inseminated on Day 0 with fresh semen spiked with a field strain of LSDV on day 0. Six of the heifers were superovulated on Day 1 using pregnant mare serum gonadotropin, and embryos were flushed from these heifers on Day 6. Blood and serum samples were collected from Day 4 until Day 27 to determine the presence of LSDV by PCR and virus isolation, and the presence of antibodies against LSDV by SNT. The first clinical signs of LSD were noticed on Day 10, followed by severe generalized LSD in three heifers and mild LSD in two more heifers. Two heifers were humanely euthanized due to severe unresponsive stranguria. LSDV was detected by PCR, virus isolation or electron microscopy in blood, embryos and organs of experimentally infected animals; and eight heifers had seroconverted by Day 27. Two control animals were not affected. This is the first report of experimental seminal transmission of LSDV in cattle.
© 2013 Blackwell Verlag GmbH.

Entities:  

Keywords:  artificial insemination; embryo; lumpy skin disease virus; semen; transmission

Mesh:

Year:  2013        PMID: 23289592     DOI: 10.1111/tbed.12045

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  12 in total

1.  Assessment of the control measures of the Category A diseases of the Animal Health Law: prohibitions in restricted zones and risk-mitigating treatments for products of animal origin and other materials.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Karl Stahl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Ylva Sjunnesson; Andrea Gervelmeyer; Helen Clare Roberts
Journal:  EFSA J       Date:  2022-08-09

Review 2.  Lumpy skin disease, an emerging transboundary viral disease: A review.

Authors:  Fatemeh Namazi; Azizollah Khodakaram Tafti
Journal:  Vet Med Sci       Date:  2021-02-01

3.  Assessment of the control measures for category A diseases of Animal Health Law: Lumpy Skin Disease.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Liisa Helena Sihvonen; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Simon Gubbins; Eyal Klement; Jan Arend Stegeman; Sotiria-Eleni Antoniou; Inma Aznar; Alessandro Broglia; Yves Van der Stede; Gabriele Zancanaro; Helen Clare Roberts
Journal:  EFSA J       Date:  2022-01-24

4.  Minimum Infective Dose of a Lumpy Skin Disease Virus Field Strain from North Macedonia.

Authors:  Janika Wolff; Kiril Krstevski; Martin Beer; Bernd Hoffmann
Journal:  Viruses       Date:  2020-07-16       Impact factor: 5.048

5.  Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus.

Authors:  Janika Wolff; Tom Moritz; Kore Schlottau; Donata Hoffmann; Martin Beer; Bernd Hoffmann
Journal:  Vaccines (Basel)       Date:  2020-12-23

6.  Quantifying and Modeling the Acquisition and Retention of Lumpy Skin Disease Virus by Hematophagus Insects Reveals Clinically but Not Subclinically Affected Cattle Are Promoters of Viral Transmission and Key Targets for Control of Disease Outbreaks.

Authors:  Simon Gubbins; Philippa M Beard; Beatriz Sanz-Bernardo; Ismar R Haga; Najith Wijesiriwardana; Sanjay Basu; Will Larner; Adriana V Diaz; Zoë Langlands; Eric Denison; Joanne Stoner; Mia White; Christopher Sanders; Philippa C Hawes; Anthony J Wilson; John Atkinson; Carrie Batten; Luke Alphey; Karin E Darpel
Journal:  J Virol       Date:  2021-04-12       Impact factor: 5.103

7.  Characterization of sheep pox virus vaccine for cattle against lumpy skin disease virus.

Authors:  Eeva S M Tuppurainen; Caroline R Pearson; Katarzyna Bachanek-Bankowska; Nick J Knowles; Shadi Amareen; Lorraine Frost; Mark R Henstock; Charles E Lamien; Adama Diallo; Peter P C Mertens
Journal:  Antiviral Res       Date:  2014-06-25       Impact factor: 5.970

Review 8.  Review: Capripoxvirus Diseases: Current Status and Opportunities for Control.

Authors:  E S M Tuppurainen; E H Venter; J L Shisler; G Gari; G A Mekonnen; N Juleff; N A Lyons; K De Clercq; C Upton; T R Bowden; S Babiuk; L A Babiuk
Journal:  Transbound Emerg Dis       Date:  2015-11-13       Impact factor: 5.005

9.  Characterization of a Nigerian Lumpy Skin Disease Virus Isolate after Experimental Infection of Cattle.

Authors:  Janika Wolff; Eeva Tuppurainen; Adeyinka Adedeji; Clement Meseko; Olayinka Asala; Jolly Adole; Rebecca Atai; Banenat Dogonyaro; Anja Globig; Donata Hoffmann; Martin Beer; Bernd Hoffmann
Journal:  Pathogens       Date:  2021-12-23

Review 10.  Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences.

Authors:  Elizabeth A Clemmons; Kendra J Alfson; John W Dutton
Journal:  Animals (Basel)       Date:  2021-07-08       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.